Xuedan Sun

Dr. Xuedan Sun


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2024 in Cell Discovery
Verified
Journal Article
Open access
PDF file
YHYabin Huang
Yabin Huang
FMFanzheng Meng
Fanzheng Meng
TZTaofei Zeng
Taofei Zeng
RTRick Francis THORNE
Rick Francis THORNE
LHLifang He
Lifang He
Lianxin LiuLianxin Liu
Lianxin Liu
Glutamine addiction represents a metabolic vulnerability of cancer cells; however, effective therapeutic targeting of the pathways involved remains to be realized. Here, we disclose the critical role of interferon-related developmental regulator 1 (IFRD1) in the adaptive survival of hepatocellular carcinoma (HCC) cells during glutamine starvation. IFRD1 is induced under glutamine starvation to inhibit autophagy by promoting the proteasomal degradation of the key autophagy regulator ATG14 in a TRIM21-dependent manner. Conversely, targeting IFRD1 in the glutamine-deprived state increases autophagy flux, triggering cancer cell exhaustive death. This effect largely results from the nucleophilic degradation of histone H1.0 and the ensuing unchecked increases in ribosome and protein biosynthesis associated with globally enhanced chromatin accessibility. Intriguingly, IFRD1 depletion in preclinical HCC models synergizes with the treatment of the glutaminase-1 selective inhibitor CB-839 to potentiate the effect of limiting glutamine. Together, our findings reveal how IFRD1 supports the adaptive survival of cancer cells under glutamine starvation, further highlighting the potential of IFRD1 as a therapeutic target in anti-cancer applications.

18 March 2026 in Journal of Hepatology
Verified
Journal Article
Closed access
TZTaofei Zeng
Taofei Zeng
YHYabin Huang
Yabin Huang
HHHao He
Hao He
JCJiuxiang Chang
Jiuxiang Chang
STShengwei Tao
Shengwei Tao
DYDa-Long Yin
Da-Long Yin

19 March 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
RLRuyi Liu
Ruyi Liu
TWTao Wang
Tao Wang
CWChunxu Wang
Chunxu Wang
MXMingyou Xu
Mingyou Xu
BCBoyu Chen
Boyu Chen
Lianxin LiuLianxin Liu
Lianxin Liu
G-quadruplex DNA (G4-DNA), a noncanonical tetrahelical nucleic acid structure stabilized by stacked G-quartets via Hoogsteen hydrogen bonding, plays critical roles in genomic regulation and disease pathogenesis. Current methodologies for detecting these structures face limitations in specificity, spatiotemporal resolution, and live-cell applicability. To address these challenges, we engineered G4-Flame, a genetically encoded fluorescent biosensor utilizing circularly permuted fluorescent protein technology. By strategically positioning a G4-specific binding domain proximal to the fluorophore of circularly permuted YFP (cpYFP), G4-Flame achieves real-time, high-resolution visualization of G4-DNA dynamics in living systems, with specificity across diverse G4 conformations. Experimental validation revealed distinct spatiotemporal patterns of G4-DNA during the cell cycle: nuclear G4-DNA levels peaked during the S phase, while mitochondrial G4-DNA was found to suppress the expression of mitochondrial-encoded genes. Clinically, serum analysis revealed significantly elevated G4-DNA levels in cancer patients compared to healthy controls. This work establishes G4-Flame as a transformative tool for investigating G4-DNA spatiotemporal regulation and advances its potential as a biomarker for early cancer detection, bridging fundamental research with clinical translation.

23 October 2025 in Bioconjugate Chemistry
Verified
Journal Article
Open access
MXMingyou Xu
Mingyou Xu
CWChunxu Wang
Chunxu Wang
RLRuyi Liu
Ruyi Liu
LWLili Wang
Lili Wang
WXWanxiang Xiong
Wanxiang Xiong
XSXifu Shang
Xifu Shang
Cysteine sulfenylation (Cys-SOH) is a transient redox-sensitive post-translational modification that regulates protein activity and cellular stress responses, yet its in vivo dynamics remain difficult to capture due to short half-life and low abundance. Here, we report the design and application of BTD-Az, a cell-permeable probe that incorporates an azide handle into the benzothiazine scaffold, enabling rapid bioorthogonal labeling of Cys-SOH both in vivo and in vitro, followed by efficient enrichment through strain-promoted azide-alkyne cycloaddition. This approach streamlines the detection and analysis of Cys-SOH with exceptional specificity and convenience. BTD-Az exhibited negligible cytotoxicity, efficiently enriched sulfenylated proteins in vitro, and achieved direct in vivo labeling in mouse tissues through SPAAC-mediated pull-down. Coupling BTD-Az with 4D-DIA proteomics allowed global sulfenylome profiling, revealing >5000 labeled proteins across tissues. As a proof-of-concept biological application, we applied BTD-Az to aging cartilage and identified 95 proteins with differential sulfenylation, including the mitochondrial enzyme IDH2, whose Cys-SOH modification promoted proteasomal degradation and exacerbated redox imbalance. Collectively, this study establishes BTD-Az as a robust chemical tool for in vivo sulfenylation profiling, providing a broadly applicable platform for redox proteomics and the discovery of redox-sensitive regulatory mechanisms in health and disease.

14 June 2026 in Cancer Letters
Verified
Journal Article
Closed access
WXWanxiang Xiong
Wanxiang Xiong
XSXiuhui Shi
Xiuhui Shi
SPShixiang Pan
Shixiang Pan
HLHairui Li
Hairui Li
GYGuang Yang
Guang Yang
RSRuipeng Song
Ruipeng Song

21 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHongrui Zhu
Hongrui Zhu
LWLi Wang
Li Wang
QWQi Wu
Qi Wu
YYYanwei Yu
Yanwei Yu
MYMengmeng Yang
Mengmeng Yang
Qingsong HuQingsong Hu
Qingsong Hu
Reactivating quiescent tumor cells at the invasive margin are either eliminated by immune surveillance or expand through immune escape. The mechanisms underpinning phenotypic plasticity driving expansion leading to therapeutic resistance, dissemination, and recurrence remain elusive. Here we establish a metabolic licensing paradigm wherein reactive astrocytes awaken dormant glioblastoma cells and simultaneously confer immune evasion through intercellular mitochondrial transfer. Astrocyte-derived mitochondria, enriched with the one carbon metabolism enzyme SHMT2, deliver functional metabolic units that reprogram recipient glioma cells. This shuttled cargo fuels S adenosylmethionine production, driving m⁶A RNA methylation and release of paused RNA polymerase II over a specific set of genes. Ribosome biogenesis and focal adhesion pathways are selectively upregulated consequently, which enables rapid proliferation and immune resistance of tumour cells. Genetic ablation of astrocytic Shmt2 or pharmacological blockade of mitochondrial transfer suppresses quiescent cell reactivation and delays tumor progression. Our findings thus establish the astrocyte-mitochondria shuttle as a core vulnerability in glioblastomas, linking metabolic crosstalk to epitranscriptomic control of reactivation and immune escape.